Is Gerresheimer AG a good investment? Gerresheimer AG (GXI.DE) is currently trading at 25.00 EUR. Market analysts have a consensus price target of 24.04 EUR. This suggests the asset is currently trading above analyst expectations.
In terms of valuation, the stock trades at a P/E ratio of 36.24. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Gerresheimer AG is expected to release its next earnings report on June 10, 2026. The market consensus estimate for Forward EPS is 2.67.
For income investors, Gerresheimer AG pays a dividend yield of 0.14%. With a payout ratio of 14%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.04 EUR (0.14% yield).
Gerresheimer AG is classified as a Stock. You can compare it against 10 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be June 10, 2026. The company currently has a trailing EPS of 0.68.
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. It serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
0.14% (5y avg: 1.37%)
0.04 EUR
June 6, 2025
14.49%
| Year | Total Dividends |
|---|---|
| 2026 | 0.04 EUR |
| June 10, 2026 (estimated) | 0.0404 |
| 2025 | 0.04 EUR |
| June 10, 2025 | 0.0400 |
| 2024 | 1.25 EUR |
| June 10, 2024 | 1.2500 |
| 2023 | 1.25 EUR |
| June 12, 2023 | 1.2500 |
| 2022 | 1.25 EUR |
| June 13, 2022 | 1.2500 |
| 2021 | 1.25 EUR |
| June 14, 2021 | 1.2500 |
| 2020 | 1.20 EUR |
| June 29, 2020 | 1.2000 |
| 2019 | 1.15 EUR |
| June 12, 2019 | 1.1500 |
| 2018 | 1.10 EUR |
| April 30, 2018 | 1.1000 |
| 2017 | 1.05 EUR |
| May 2, 2017 | 1.0500 |
| 2016 | 0.85 EUR |
| April 29, 2016 | 0.8500 |
| 2015 | 0.75 EUR |
| May 4, 2015 | 0.7500 |
| 2014 | 0.70 EUR |
| May 2, 2014 | 0.7000 |
| 2013 | 0.65 EUR |
| April 19, 2013 | 0.6500 |
| 2012 | 0.60 EUR |
| April 27, 2012 | 0.6000 |
| 2011 | 0.50 EUR |
| April 15, 2011 | 0.5000 |
| 2009 | 0.40 EUR |
| April 30, 2009 | 0.4000 |
| 2008 | 0.40 EUR |
| May 26, 2008 | 0.4000 |
Yearly aggregated dividends
|
Gerresheimer AG
Jun 10, 2025 Paid
Dividend
0.04 EUR |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion